Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra L Starnes

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The Journal of Thoracic and Cardiovascular Surgery|July 5, 2011
The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 14, 2014
First nationwide survey of US integrated 6-year cardiothoracic surgical residency program directorsAmir H Lebastchi, John J Tackett, Michael Argenziano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancerHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 16, 2014
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Nature Communications|July 26, 2022
Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancerCaterina Bartolacci, Cristina Andreani, Gonçalo Vale, et al.
Nature Communications|August 8, 2022
Author Correction: Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancerCaterina Bartolacci, Cristina Andreani, Gonçalo Vale, et al.
The Journal of Clinical Investigation|February 7, 2009
Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like diseaseMichael T Borchers, Scott C Wesselkamper, Victor Curull, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The Journal of Thoracic and Cardiovascular Surgery|July 5, 2011
The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 14, 2014
First nationwide survey of US integrated 6-year cardiothoracic surgical residency program directorsAmir H Lebastchi, John J Tackett, Michael Argenziano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancerHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 16, 2014
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Nature Communications|July 26, 2022
Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancerCaterina Bartolacci, Cristina Andreani, Gonçalo Vale, et al.
Nature Communications|August 8, 2022
Author Correction: Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancerCaterina Bartolacci, Cristina Andreani, Gonçalo Vale, et al.
The Journal of Clinical Investigation|February 7, 2009
Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like diseaseMichael T Borchers, Scott C Wesselkamper, Victor Curull, et al.
Pageof 6